MedKoo Cat#: 145796 | Name: Metahexestrol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Metahexestrol is a synthetic chemical compound that belongs to the class of stilbene derivatives. It is known for its estrogenic properties, meaning it can mimic the action of estrogen, a key hormone in the body. Metahexestrol has been studied for its potential use in hormone-related therapies, particularly in cases involving menopausal symptoms or hormone replacement therapy.

Chemical Structure

Metahexestrol
CAS#71953-72-5

Theoretical Analysis

MedKoo Cat#: 145796

Name: Metahexestrol

CAS#: 71953-72-5

Chemical Formula: C18H22O2

Exact Mass: 270.1600

Molecular Weight: 270.37

Elemental Analysis: C, 79.96; H, 8.20; O, 11.83

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Metahexestrol; NSC366211; NSC-366211; NSC 366211; NSC297170; NSC-297170; NSC 297170;
IUPAC/Chemical Name
3,3'-((3R,4S)-hexane-3,4-diyl)diphenol
InChi Key
KUJAWCSIKNKXLL-HDICACEKSA-N
InChi Code
1S/C18H22O2/c1-3-17(13-7-5-9-15(19)11-13)18(4-2)14-8-6-10-16(20)12-14/h5-12,17-20H,3-4H2,1-2H3/t17-,18+
SMILES Code
CC[C@@H]([C@@H](CC)C1=CC(O)=CC=C1)C2=CC=CC(O)=C2
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 270.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gupta SP, Handa A. Quantitative structure-activity relationship study on hexestrol and metahexestrol derivatives interacting with estrogen receptors. Res Commun Chem Pathol Pharmacol. 1987 Mar;55(3):357-66. PMID: 3033781. 2: Hartmann RW, Heindl A, Schönenberger H. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols. J Med Chem. 1984 May;27(5):577-85. doi: 10.1021/jm00371a004. PMID: 6325689. 3: Hartmann RW. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens. J Med Chem. 1986 Sep;29(9):1668-74. doi: 10.1021/jm00159a018. PMID: 3018243. 4: Kranzfelder G, Hartmann RW, von Angerer E, Schönenberger H, Bogden AE. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. J Cancer Res Clin Oncol. 1982;103(2):165-80. doi: 10.1007/BF00409646. PMID: 6284766. 5: Hartmann RW, Buchborn H, Kranzfelder G, Schönenberger H, Bogden A. Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes. J Med Chem. 1981 Oct;24(10):1192-7. doi: 10.1021/jm00142a014. PMID: 6276542. 6: Hartmann RW. Tumor growth-stimulating and inhibiting effects of antiestrogens on the DMBA-induced mammary carcinoma of the ovariectomized, diethylstilbestrol- treated SD rat. A study on the mechanism of action of antiestrogens. Eur J Cancer Clin Oncol. 1983 Jul;19(7):959-64. doi: 10.1016/0277-5379(83)90065-2. PMID: 6309529. 7: Hartmann RW, Schönenberger H, Wrobel KH. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat. J Cancer Res Clin Oncol. 1982;103(3):241-54. doi: 10.1007/BF00409700. PMID: 6288725. 8: Hartmann RW. Screening procedure for the development of mammary tumour- inhibiting anti-oestrogens. Cancer Treat Rev. 1984 Mar;11 Suppl A:155-61. doi: 10.1016/0305-7372(84)90055-0. PMID: 6329512.